Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells-Reference-Cited by-同舟云学术

Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells

Published:2018-11-08 Issue:5 Volume:60 Page:1299-1303
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Rodriguez Cecilia M.¹²,Bussi Claudio²,Arroyo Daniela S.¹²,Sastre Dario¹,Heller Viviana¹,Stanganelli Carmen³,Slavutsky Irma⁴,Iribarren Pablo²

Affiliation:

1. Hospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina;

2. Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI-CONICET) Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina;

3. Patología Molecular, Instituto de Investigaciones Hematológicas Academia Nacional de Medicina, Buenos Aires, Argentina;

4. Laboratorio de Genética de Neoplasias Linfoides, Instituto de Medicina Experimental, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina

Funder

Fondo para la Investigación Científica y Tecnológica

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1529309

Reference17 articles.

1. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

2. B cell receptor signaling in chronic lymphocytic leukemia

3. CD38 and chronic lymphocytic leukemia: a decade later